ment, he says. Yet he resists the sugges tion that breeding success is simply a function of how much a company spends. He argues com petitive advantage increasingly lies in how efficiently com panies connect the different parts of their breeding systems. Field testing must generate reliable data that moves quickly into genomic prediction models. Crosses must happen soon enough to take advantage of subse quent breeding cycles, includ ing counter-season nurseries. Seed and information must then return to testing loca tions in time to inform the next round of selection. GDM can complete as many as five soybean breed ing cycles or four corn cycles annually thanks to its global breeding capabilities, Bartolomé says. "You can be very good at one piece of that puzzle, but if you don't put them all together at the right speed, in an efficient way, with good data and timing, you're not going to have an impact in a real product." Genetics First. Traits Second. The company breeds with more than 30 GMO trait platforms globally, according to Bartolomé, allowing it to develop genetics compatible with technologies from multiple suppliers. He sees that flexibility as fundamental to GDM's business model. "The engine is the genet ics. The airbag is the trait. You can have a car with no airbag, but you cannot have a car with no engine," he says. Trait developers might dis pute the relative importance he assigns to each, but it explains why GDM has built its business around germplasm while maintaining access to competing technologies. Can GDM Grow Without Losing Its Advantage? Integrating AgReliant required changes that went well beyond GDM's breeding and commercial operations. GDM reduced management layers and reorganized the former AgReliant business to put commercial teams closer to farmers and distributors. Bartolomé wants an organ ization capable of making decisions quickly, including when solving a customer's problem means working around established processes. Maintaining that flexibility could become harder as GDM grows, but he considers it fundamental. "You are a farmer, you start farming at 25, you retire at 65, you get 40 times in your life to make [your crop] right," he says. "That's only 40 chances that we get as a seed company to sell seed to that farmer. We need to get it right because it's a trust business." A poorly performing product or a missed delivery commitment can damage relationships that take years to rebuild. Bartolomé’s biggest concern is to balance that agile approach with build ing the trusted relationships needed to sustain growth. Competitors Welcome GDM's ambitions extend beyond increasing sales through its own brands. Bartolomé wants the company to become a larger supplier of genetics and breeding technologies across the U.S. seed value chain. Potential partners include independent seed companies seeking germ plasm, businesses needing breeding technologies, distributors looking for specific trait and genetics combinations, and grain processors interested in specialized products. "We like collaboration, and we think that's the way of making products better faster," he says. For independent seed companies, GDM's grow ing genetic portfolio and access to multiple trait platforms could mean more choice in what they bring to market, even as GDM's own brands compete for the same customers. Bartolomé admits huge personal satisfaction in seeing GDM tackle the U.S. corn market. His father founded the business in Argentina, and Bartolomé speaks with pride about how far it has come, particularly its ability to challenge estab lished multinationals in crops and markets once beyond its reach. Yet when asked what excites him most about his work, he talks about the response from farmers: a photograph of a promis ing crop, praise for a new variety, a combine monitor showing an exceptional yield. "I like the technology piece, but at the end, tech nology for the sake of tech nology, I think it's irrelevant." “If we have a good product, then we can sit at the table. If we don't have a good product, we cannot sit at the table. The farmer gets paid by bushels per acre. SW 8 / SEEDWORLD.COM DECEMBER 2026 GDM is also developing its own technologies. Bartolomé expects the company to intro duce proprietary biotech trait solutions in the mid-2030s, complementing existing com mercial platforms. Gene editing is another major investment area. Through its North Carolina- based Traits Company, established in 2022, GDM is developing gene-edited products for North and South American markets. Bartolomé sees gene edit ing primarily as an exten sion of breeding rather than simply another approach to trait development. GDM intends to supply genetics and technologies to other seed businesses while competing through its own brands, potentially giving companies more options for combining germplasm and trait platforms. “We need to be in corn to be important in the U.S. We need to be in the U.S. to be important globally.” -GDM CEO Ignacio Bartolomé
View this content as a flipbook by clicking here.